Clinical Trial Update: Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the safety, pharmacokinetics, and activity of GDC-1971 in combination with osimertinib for unresectable, locally advanced, or metas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• GDC-1971
• Osimertinib (osimertinib)

Snippet

Sponsor: Genentech, Inc. | Conditions: Colorectal Cancer, Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED